Last10K.com

Gri Bio, Inc. (GRI) SEC Filing DEF 14A Proxy Statement Report for the fiscal year ending Tuesday, January 2, 2024

Gri Bio, Inc.

HISTORY TOOLS
CIK: 1824293 Ticker: GRI

View differences made from one to another to evaluate Gri Bio, Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this Proxy Statements Form DEF 14A to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Gri Bio, Inc..

Continue

Assess how Gri Bio, Inc.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Gri Bio, Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

SEC Filing Tools
Ticker: GRI
CIK: 1824293
Form Type: Proxy Statements Form DEF 14A
Accession Number: 0001824293-23-000187
Submitted to the SEC: Fri Dec 29 2023 5:57:45 PM EST
Accepted by the SEC: Tue Jan 02 2024
Period: Tuesday, January 2, 2024
Industry: Pharmaceutical Preparations

External Resources:
Stock Quote
Social Media
SEC.gov

Bookmark the Permalink:
https://last10k.com/sec-filings/gri/0001824293-23-000187.htm